840 related articles for article (PubMed ID: 18314197)
21. Clinical isolates of Staphylococcus aureus from the Arkhangelsk region, Russia: antimicrobial susceptibility, molecular epidemiology, and distribution of Panton-Valentine leukocidin genes.
Vorobieva V; Bazhukova T; Hanssen AM; Caugant DA; Semenova N; Haldorsen BC; Simonsen GS; Sundsfjord A
APMIS; 2008 Oct; 116(10):877-87. PubMed ID: 19132981
[TBL] [Abstract][Full Text] [Related]
22. Patients at risk of complications of Staphylococcus aureus bloodstream infection.
del Rio A; Cervera C; Moreno A; Moreillon P; Miró JM
Clin Infect Dis; 2009 May; 48 Suppl 4():S246-53. PubMed ID: 19374580
[TBL] [Abstract][Full Text] [Related]
23. Epidemic spread of a single clone of methicillin-resistant Staphylococcus aureus among injection drug users in Zurich, Switzerland.
Fleisch F; Zbinden R; Vanoli C; Ruef C
Clin Infect Dis; 2001 Feb; 32(4):581-6. PubMed ID: 11181121
[TBL] [Abstract][Full Text] [Related]
24. Management of methicillin-resistant Staphylococcus aureus bacteremia.
Cosgrove SE; Fowler VG
Clin Infect Dis; 2008 Jun; 46 Suppl 5():S386-93. PubMed ID: 18462094
[TBL] [Abstract][Full Text] [Related]
25. Staphylococcus aureus septicemia in non-neutropenic adult patients hospitalized in internal medicine units.
Gallucci F; Amato G; Esposito P; Belli CM; Russo R; Uomo G
Rocz Akad Med Bialymst; 2005; 50():216-9. PubMed ID: 16358970
[TBL] [Abstract][Full Text] [Related]
26. Persistent Staphylococcus aureus bacteremia: an analysis of risk factors and outcomes.
Hawkins C; Huang J; Jin N; Noskin GA; Zembower TR; Bolon M
Arch Intern Med; 2007 Sep; 167(17):1861-7. PubMed ID: 17893307
[TBL] [Abstract][Full Text] [Related]
27. Outcome of Staphylococcus aureus bacteremia in patients with eradicable foci versus noneradicable foci.
Kim SH; Park WB; Lee KD; Kang CI; Kim HB; Oh MD; Kim EC; Choe KW
Clin Infect Dis; 2003 Sep; 37(6):794-9. PubMed ID: 12955640
[TBL] [Abstract][Full Text] [Related]
28. [Right endocarditis caused by Staphylococcus aureus in parenteral drug addicts: evaluation of a combined therapeutic scheme for 2 weeks versus conventional treatment].
Espinosa FJ; Valdés M; Martín-Luengo F; Arribas JP; Albaladejo J; Pérez-Gracia A; García-Henarejos JA; Martínez-Madrid O; García-Alberola A
Enferm Infecc Microbiol Clin; 1993 May; 11(5):235-40. PubMed ID: 8324018
[TBL] [Abstract][Full Text] [Related]
29. Staphylococcus aureus bacteraemia of unknown primary source: where do we stand?
Saginur R; Suh KN
Int J Antimicrob Agents; 2008 Nov; 32 Suppl 1():S21-5. PubMed ID: 18757183
[TBL] [Abstract][Full Text] [Related]
30. Risk of endocarditis among patients with prosthetic valves and Staphylococcus aureus bacteremia.
El-Ahdab F; Benjamin DK; Wang A; Cabell CH; Chu VH; Stryjewski ME; Corey GR; Sexton DJ; Reller LB; Fowler VG
Am J Med; 2005 Mar; 118(3):225-9. PubMed ID: 15745719
[TBL] [Abstract][Full Text] [Related]
31. Infective endocarditis in maintenance hemodialysis patients: fifteen years' experience in one medical center.
Chang CF; Kuo BI; Chen TL; Yang WC; Lee SD; Lin CC
J Nephrol; 2004; 17(2):228-35. PubMed ID: 15293522
[TBL] [Abstract][Full Text] [Related]
32. Infective endocarditis due to Staphylococcus aureus: 59 prospectively identified cases with follow-up.
Fowler VG; Sanders LL; Kong LK; McClelland RS; Gottlieb GS; Li J; Ryan T; Sexton DJ; Roussakis G; Harrell LJ; Corey GR
Clin Infect Dis; 1999 Jan; 28(1):106-14. PubMed ID: 10028079
[TBL] [Abstract][Full Text] [Related]
33. Staphylococcus aureus endocarditis: clinical manifestations in addicts and nonaddicts.
Chambers HF; Korzeniowski OM; Sande MA
Medicine (Baltimore); 1983 May; 62(3):170-7. PubMed ID: 6843356
[TBL] [Abstract][Full Text] [Related]
34. Significance of Staphylococcus lugdunensis bacteremia: report of 28 cases and review of the literature.
Zinkernagel AS; Zinkernagel MS; Elzi MV; Genoni M; Gubler J; Zbinden R; Mueller NJ
Infection; 2008 Aug; 36(4):314-21. PubMed ID: 18648747
[TBL] [Abstract][Full Text] [Related]
35. Future strategies for treating Staphylococcus aureus bloodstream infections.
Naber CK
Clin Microbiol Infect; 2008 Mar; 14 Suppl 2():26-34. PubMed ID: 18226087
[TBL] [Abstract][Full Text] [Related]
36. Panton-Valentine leukocidin is associated with exacerbated skin manifestations and inflammatory response in children with community-associated staphylococcal scarlet fever.
Lo WT; Tang CS; Chen SJ; Huang CF; Tseng MH; Wang CC
Clin Infect Dis; 2009 Oct; 49(7):e69-75. PubMed ID: 19725782
[TBL] [Abstract][Full Text] [Related]
37. Risk factors and molecular analysis of panton-valentine leukocidin-positive methicillin-resistant Staphylococcus aureus colonization in healthy children.
Lo WT; Lin WJ; Tseng MH; Wang SR; Chu ML; Wang CC
Pediatr Infect Dis J; 2008 Aug; 27(8):713-8. PubMed ID: 18600194
[TBL] [Abstract][Full Text] [Related]
38. Staphylococcus aureus infections in injection drug users: risk factors and prevention strategies.
Bassetti S; Battegay M
Infection; 2004 Jun; 32(3):163-9. PubMed ID: 15188077
[TBL] [Abstract][Full Text] [Related]
39. Risk factors for hematogenous complications of intravascular catheter-associated Staphylococcus aureus bacteremia.
Fowler VG; Justice A; Moore C; Benjamin DK; Woods CW; Campbell S; Reller LB; Corey GR; Day NP; Peacock SJ
Clin Infect Dis; 2005 Mar; 40(5):695-703. PubMed ID: 15714415
[TBL] [Abstract][Full Text] [Related]
40. Daptomycin for the treatment of gram-positive bacteremia and infective endocarditis: a retrospective case series of 31 patients.
Segreti JA; Crank CW; Finney MS
Pharmacotherapy; 2006 Mar; 26(3):347-52. PubMed ID: 16503714
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
